An innovative treatment for bladder cancer successfully prevented the recurrence of tumors and improved survival rates following surgery.

Preliminary findings were presented at the 2025 ASCO Genitourinary Cancers Symposium. 2 Investigators reported that 71% of ...

enGene (NASDAQ:ENGN) reported preliminary data from the pivotal Cohort 1 of its ongoing Phase 2 LEGEND trial evaluating ...

Real-world effectiveness and treatment patterns in patients with locally advanced or metastatic urothelial carcinoma receiving avelumab first-line maintenance in Japan: Long term follow-up from the ...

Immunocompromised patients with bladder had a higher risk of disease progression and recurrence when compared to their non-immunocompromised counterparts. Immunocompromised patients with bladder ...

While the method may sound unfamiliar, it has been clinically validated for decades and remains central to preventing recurrence and disease ...

In bladder cancer care, nurses play a critical and continuous role throughout a patient’s journey, especially during ...